[1]
Sai, Y. 2018. CRISPR-Cas9 Germline Editing: Full Steam Ahead to Revolutionary Profit or Revolutionary Public Medicine?. University of Ottawa Journal of Medicine. 8, 2 (Nov. 2018), 15–18. DOI:https://doi.org/10.18192/uojm.v8i2.3741.